Advertisement

Picture Berlin Partner Voices Peter Seeberger Chemistry Transformation 650x100px
Organisation › Details

AbCellera Biologics Inc.

AbCellera is a privately held company that engages in partnerships to discover and develop next-generation therapeutic antibodies. AbCellera’s single-cell platform integrates end-to-end capabilities for therapeutic antibody discovery through a combination of technologies including proprietary immunizations, microfluidics, high-throughput imaging, genomics, computation, and laboratory automation. Ultra-deep screening of single B cells allows unprecedented access to natural immune responses, enabling rapid isolation of large and diverse panels of high-quality lead antibodies from any species, including humans. *

 

Period Start 2012-01-01 established
  Group AbCellera (Group)
  Predecessor University of British Columbia (UBC)
Products Industry MAb
  Industry 2 single cell analysis
Person Person Hansen, Carl (AbCellera 201902 CEO)
     
Region Region Vancouver, BC
  Country Canada
  Street 2215 Yukon Street
  City V5Y 0A1 Vancouver, BC
  Tel +1-604-559-9005
    Address record changed: 2024-01-05
     
Basic data Employees B: 11 to 50 (2017-10-13)
     
    * Document for »About Section«: AbCellera Biologics, Inc.. (2/14/19). "Press Release: AbCellera Announces Multi-Target Partnership Agreement with a Top 5 Global Pharma". Vancouver, BC.
     
   
Record changed: 2023-07-10

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for AbCellera (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Top News How Covid Effects the Brain 650x300px




» top